The Psoriasis Academy draws on the experience of practicing dermatologists, GPs and allied healthcare professionals around the world. It is a central repository for specialists who are already aware of the current market but want to remain up to date on the latest treatment research and development. As well as providing an easily accessible source of information, the Psoriasis Academy aims to serve as a platform for healthcare professionals to share clinical experience.
Psoriasis is a debilitating chronic inflammatory autoimmune disease with an ever-changing treatment landscape that includes topical therapy, phototherapy, and systemic drugs (Feldman et al., 2016a).
Developed by EPG Health for Medthority. This content has been developed independently of the sponsor Almirall S.A, who have had no editorial input into the content. EPG Health received educational funding from the sponsor in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.